Upexi to Host Fiscal 2023 Full Year Financial Results Conference Call on October 2nd at 4:30 PM ET

9/28/23 4:15:00 PM ET

Medicinal Chemicals and Botanical Products

Health Care

Get the next $UPXI alert in real time by email

CLEARWATER, FL / ACCESSWIRE / September 28, 2023 / Upexi Inc. (NASDAQ:UPXI) (the "Company" or "Upexi"), a multi-faceted Amazon and Direct-to-Consumer brand owner and innovator in aggregation, today announced it will host a conference call on Monday, October 2, 2023 at 4:30 p.m. ET, to discuss its financial results for the fiscal 2023 full year and provide a business update.

Financial Results Conference Call

Event:	Fiscal 2023 Full Year Financial Results Conference Call
Date:	Monday, October 2, 2023
Time:	4:30 p.m. Eastern Time
Live Call:	1-877-407-9716 (U.S. Toll-Free) or 1-201-493-6779 (International)
Webcast:	https://viavid.webcasts.com/starthere.jsp?ei=1634526&tp_key=7536fca2fa

For those unable to join the conference call, a dial-in replay of the call will be available until October 16, 2023 and can be accessed by dialing +1-844-512-2921 (U.S. Toll Free) or +1-412-317-6671 (International) and entering replay pin number: 13741232. Additional details are available under the Investor Relations section of the Company's website: https://upexi.com/investors.

About Upexi, Inc.
Upexi is a multifaceted brand owner with established brands in the health, wellness, pet, beauty and other growing markets. We operate in emerging industries with high growth trends and look to drive organic growth of our current brands. We focus on direct to consumer and Amazon brands that are scalable and have anticipated, high industry growth trends. Our goal is to continue to accumulate consumer data and build out a significant customer database across all industries we sell into. The growth of our current database has been key to the year over year gains in sales and profits. To drive additional growth, we have and will continue to acquire profitable Amazon and eCommerce businesses that can scale quickly and reduce costs through corporate synergies. We utilize our in-house, SaaS programmatic ad technology to help achieve a lower cost per acquisition and accumulate consumer data for increased cross-selling between our growing portfolio of brands.

Company Contact
Andrew Norstrud, Chief Financial Officer
Email: [email protected]
Phone: (702) 332-5591

Investor Relations Contact
KCSA Strategic Communications
Valter Pinto or Jack Perkins
Email: [email protected]
Phone: (212) 896-1254

Media Contact
Amanda York
[email protected]

SOURCE: Upexi, Inc.

View source version on accesswire.com:
https://www.accesswire.com/788494/upexi-to-host-fiscal-2023-full-year-financial-results-conference-call-on-october-2nd-at-430-pm-et

Get the next $UPXI alert in real time by email

Upexi to Host Fiscal 2023 Full Year Financial Results Conference Call on October 2nd at 4:30 PM ET

Chat with this insight

Recent Analyst Ratings for
$UPXI

$UPXI
Financials

Live finance-specific insights

Upexi Regains Compliance with NASDAQ

Upexi Reports Fiscal Second Quarter 2024 Financial Results

Upexi to Host Fiscal 2024 Second Quarter Financial Results Conference Call on February 14th at 4:30 PM ET

$UPXI
SEC Filings

Upexi Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

SEC Form S-1 filed by Upexi Inc.

Upexi Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

$UPXI
Press Releases

Fastest customizable press release news feed in the world

BitGo and Upexi Announce Strategic Partnership to Secure Digital Asset Treasury Holdings

Upexi Regains Compliance with NASDAQ

Mangoceuticals, Inc. Initiates Investigation into Potential Stock Manipulation Scheme Following Recent Reverse Stock Split

$UPXI
Large Ownership Changes

This live feed shows all institutional transactions in real time.

SEC Form SC 13G filed by Upexi Inc.

SEC Form SC 13G filed by Upexi Inc.

SEC Form SC 13G/A filed by Upexi Inc. (Amendment)

$UPXI
Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

Chief Executive Officer Marshall Allan bought $1,500,001 worth of shares (657,895 units at $2.28) and was granted 75,000 shares, increasing direct ownership by 484% to 884,318 units (SEC Form 4)

SEC Form 4 filed by Director Williams Thomas Charles

Chief Financial Officer Norstrud Andrew James bought $100,001 worth of shares (43,860 units at $2.28) and was granted 100,000 shares, increasing direct ownership by 942% to 159,138 units (SEC Form 4)

$UPXI
Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

Chief Executive Officer Marshall Allan bought $1,500,001 worth of shares (657,895 units at $2.28) and was granted 75,000 shares, increasing direct ownership by 484% to 884,318 units (SEC Form 4)

Chief Financial Officer Norstrud Andrew James bought $100,001 worth of shares (43,860 units at $2.28) and was granted 100,000 shares, increasing direct ownership by 942% to 159,138 units (SEC Form 4)

Director Salkind Gene bought $550,002 worth of shares (241,229 units at $2.28), increasing direct ownership by 195% to 365,127 units (SEC Form 4)

Upexi to Host Fiscal 2023 Full Year Financial Results Conference Call on October 2nd at 4:30 PM ET

Chat with this insight

Recent Analyst Ratings for $UPXI

$UPXI Financials

Live finance-specific insights

Upexi Regains Compliance with NASDAQ

Upexi Reports Fiscal Second Quarter 2024 Financial Results

Upexi to Host Fiscal 2024 Second Quarter Financial Results Conference Call on February 14th at 4:30 PM ET

$UPXI SEC Filings

Upexi Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

SEC Form S-1 filed by Upexi Inc.

Upexi Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

$UPXI Press Releases

Fastest customizable press release news feed in the world

BitGo and Upexi Announce Strategic Partnership to Secure Digital Asset Treasury Holdings

Upexi Regains Compliance with NASDAQ

Mangoceuticals, Inc. Initiates Investigation into Potential Stock Manipulation Scheme Following Recent Reverse Stock Split

$UPXI Large Ownership Changes

This live feed shows all institutional transactions in real time.

SEC Form SC 13G filed by Upexi Inc.

SEC Form SC 13G filed by Upexi Inc.

SEC Form SC 13G/A filed by Upexi Inc. (Amendment)

$UPXI Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

Chief Executive Officer Marshall Allan bought $1,500,001 worth of shares (657,895 units at $2.28) and was granted 75,000 shares, increasing direct ownership by 484% to 884,318 units (SEC Form 4)

SEC Form 4 filed by Director Williams Thomas Charles

Chief Financial Officer Norstrud Andrew James bought $100,001 worth of shares (43,860 units at $2.28) and was granted 100,000 shares, increasing direct ownership by 942% to 159,138 units (SEC Form 4)

$UPXI Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

Chief Executive Officer Marshall Allan bought $1,500,001 worth of shares (657,895 units at $2.28) and was granted 75,000 shares, increasing direct ownership by 484% to 884,318 units (SEC Form 4)

Chief Financial Officer Norstrud Andrew James bought $100,001 worth of shares (43,860 units at $2.28) and was granted 100,000 shares, increasing direct ownership by 942% to 159,138 units (SEC Form 4)

Director Salkind Gene bought $550,002 worth of shares (241,229 units at $2.28), increasing direct ownership by 195% to 365,127 units (SEC Form 4)

Recent Analyst Ratings for
$UPXI

$UPXI
Financials

$UPXI
SEC Filings

$UPXI
Press Releases

$UPXI
Large Ownership Changes

$UPXI
Insider Trading

$UPXI
Insider Purchases